Latest News
Latest News and Events
- All
- Events
- Featured
- Imspex Clinical
- Imspex Industrial
BreathSpec’s Proven Accuracy on Breath Analysis
What’s your FlavourSpec this Oktoberfest?
Co-Vid 19 Resilience Innovation success
Talking about breath analysis on Radio IntereconomĂa
Moving the momentum forward with Imspex Medical
Pipeline Corner for Diagnostics at ECCMID 2021
Setting the standard for siloxane measurement in biomethane testing
Breath analysis as a rapid diagnostic for respiratory tract infections
BreathSpec® features at ADTCA 2021
Hepatocellular carcinoma urinary biomarker detection using GC-IMS
Taking breath analysis into the future
A patent for our technology

ECCMID 2023
Our Group CEO John McKinley will be attending the ECCMID 2023 in Copenhagen, Denmark on Monday 17th April. We look forward to seeing you there!

MediWales Connects NHS Collaboration Conference 2023
29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with

BioWales in London
Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March

Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th

Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is

Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic











